The same in other media
Moderna: COVID booster effective against omicron in tests, will still develop new shot
Reading now: 951
CAMBRIDGE, Mass. - Moderna said Monday that its COVID-19 vaccine booster appears to provide protection against the rapidly-spreading omicron variant of the coronavirus, but it will still continue work developing a new shot specific to the strain.
The drug company said in a statement that preliminary data showed its booster shot currently being used in the U.S. and abroad increased neutralizing antibody levels against omicron 37-fold compared to pre-boost levels.
A double dose of the booster — 100ug — provided an 83-fold increase in neutralizing antibody levels, the company said.The news comes amid warnings about the variant’s rapid spread around the world, which has been detected in at least 89 countries.
Read more on fox29.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
COVID-19
United States
|
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
|
India
|
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
|
Brazil
|
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
|
United Kingdom
|
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
|
Russia
|
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
|
